APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidepressants

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antidepressants Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchAntidepressants Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidepressants Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Antidepressants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidepressants Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidepressants Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Antidepressants market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antidepressants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antidepressants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antidepressants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antidepressants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antidepressants include Bristol-Myers Squibb Company, H Lundbeck, Sun Pharmaceuticals, Astrazeneca, GlaxoSmithKline, Pfizer Inc., Eli Lilly and Company, Merck and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antidepressants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antidepressants, also provides the sales of main regions and countries. Of the upcoming market potential for Antidepressants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antidepressants sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antidepressants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antidepressants sales, projected growth trends, production technology, application and end-user industry.

Antidepressants Segment by Company

Bristol-Myers Squibb Company

H Lundbeck

Sun Pharmaceuticals

Astrazeneca

GlaxoSmithKline

Pfizer Inc.

Eli Lilly and Company

Merck

Johnson & Johnson

Sanofi

Antidepressants Segment by Type

Benzodiazepines

Monoamine Oxidase Inhibitors

Antipsychotics

Tricyclic Antidepressants

Novel Agents

Selective Norepinephrine Reuptake Inhibitors

Selective Serotonin Reuptake Inhibitors

Antidepressants Segment by Application

Hospitals

Clinics

Other

Antidepressants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidepressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidepressants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidepressants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antidepressants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidepressants sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antidepressants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Benzodiazepines Major Manufacturers Table 3. Monoamine Oxidase Inhibitors Major Manufacturers Table 4. Antipsychotics Major Manufacturers Table 5. Tricyclic Antidepressants Major Manufacturers Table 6. Novel Agents Major Manufacturers Table 7. Selective Norepinephrine Reuptake Inhibitors Major Manufacturers Table 8. Selective Serotonin Reuptake Inhibitors Major Manufacturers Table 9. Global Antidepressants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Hospitals Major Manufacturers Table 11. Clinics Major Manufacturers Table 12. Other Major Manufacturers Table 13. Antidepressants Industry Trends Table 14. Antidepressants Industry Drivers Table 15. Antidepressants Industry Opportunities and Challenges Table 16. Antidepressants Industry Restraints Table 17. Global Antidepressants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Antidepressants Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Antidepressants Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Antidepressants Revenue Market Share by Region (2021-2026) Table 21. Global Antidepressants Revenue Market Share by Region (2027-2032) Table 22. Global Antidepressants Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Antidepressants Sales by Region (2021-2026) & (W Units) Table 24. Global Antidepressants Sales by Region (2027-2032) & (W Units) Table 25. Global Antidepressants Sales Market Share by Region (2021-2026) Table 26. Global Antidepressants Sales Market Share by Region (2027-2032) Table 27. Global Antidepressants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Antidepressants Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Antidepressants Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Antidepressants Sales Market Share by Manufacturers (2021-2026) Table 31. Global Antidepressants Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Antidepressants Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Antidepressants Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Antidepressants Manufacturers, Product Type & Application Table 35. Global Antidepressants Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Antidepressants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Antidepressants Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Antidepressants Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Antidepressants Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Antidepressants Revenue Market Share by Type (2021-2026) Table 42. Global Antidepressants Revenue Market Share by Type (2027-2032) Table 43. Global Antidepressants Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Antidepressants Sales by Type (2021-2026) & (W Units) Table 45. Global Antidepressants Sales by Type (2027-2032) & (W Units) Table 46. Global Antidepressants Sales Market Share by Type (2021-2026) Table 47. Global Antidepressants Sales Market Share by Type (2027-2032) Table 48. Global Antidepressants Price by Type (2021-2026) & (US$/Unit) Table 49. Global Antidepressants Price by Type (2027-2032) & (US$/Unit) Table 50. Global Antidepressants Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antidepressants Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Antidepressants Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Antidepressants Revenue Market Share by Application (2021-2026) Table 54. Global Antidepressants Revenue Market Share by Application (2027-2032) Table 55. Global Antidepressants Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Antidepressants Sales by Application (2021-2026) & (W Units) Table 57. Global Antidepressants Sales by Application (2027-2032) & (W Units) Table 58. Global Antidepressants Sales Market Share by Application (2021-2026) Table 59. Global Antidepressants Sales Market Share by Application (2027-2032) Table 60. Global Antidepressants Price by Application (2021-2026) & (US$/Unit) Table 61. Global Antidepressants Price by Application (2027-2032) & (US$/Unit) Table 62. Bristol-Myers Squibb Company Company Information Table 63. Bristol-Myers Squibb Company Business Overview Table 64. Bristol-Myers Squibb Company Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Bristol-Myers Squibb Company Antidepressants Product Portfolio Table 66. Bristol-Myers Squibb Company Recent Development Table 67. H Lundbeck Company Information Table 68. H Lundbeck Business Overview Table 69. H Lundbeck Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. H Lundbeck Antidepressants Product Portfolio Table 71. H Lundbeck Recent Development Table 72. Sun Pharmaceuticals Company Information Table 73. Sun Pharmaceuticals Business Overview Table 74. Sun Pharmaceuticals Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sun Pharmaceuticals Antidepressants Product Portfolio Table 76. Sun Pharmaceuticals Recent Development Table 77. Astrazeneca Company Information Table 78. Astrazeneca Business Overview Table 79. Astrazeneca Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Astrazeneca Antidepressants Product Portfolio Table 81. Astrazeneca Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Antidepressants Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Pfizer Inc. Company Information Table 88. Pfizer Inc. Business Overview Table 89. Pfizer Inc. Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Inc. Antidepressants Product Portfolio Table 91. Pfizer Inc. Recent Development Table 92. Eli Lilly and Company Company Information Table 93. Eli Lilly and Company Business Overview Table 94. Eli Lilly and Company Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Eli Lilly and Company Antidepressants Product Portfolio Table 96. Eli Lilly and Company Recent Development Table 97. Merck Company Information Table 98. Merck Business Overview Table 99. Merck Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Merck Antidepressants Product Portfolio Table 101. Merck Recent Development Table 102. Johnson & Johnson Company Information Table 103. Johnson & Johnson Business Overview Table 104. Johnson & Johnson Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Johnson & Johnson Antidepressants Product Portfolio Table 106. Johnson & Johnson Recent Development Table 107. Sanofi Company Information Table 108. Sanofi Business Overview Table 109. Sanofi Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sanofi Antidepressants Product Portfolio Table 111. Sanofi Recent Development Table 112. North America Antidepressants Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Antidepressants Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Antidepressants Sales by Type (2021-2026) & (W Units) Table 115. North America Antidepressants Sales by Type (2027-2032) & (W Units) Table 116. North America Antidepressants Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Antidepressants Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Antidepressants Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Antidepressants Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Antidepressants Sales by Application (2021-2026) & (W Units) Table 121. North America Antidepressants Sales by Application (2027-2032) & (W Units) Table 122. North America Antidepressants Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Antidepressants Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Antidepressants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Antidepressants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Antidepressants Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 128. North America Antidepressants Sales by Country (2021-2026) & (W Units) Table 129. North America Antidepressants Sales by Country (2027-2032) & (W Units) Table 130. North America Antidepressants Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Antidepressants Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Antidepressants Revenue (2021-2032) & (US$ Million) Table 133. Canada Antidepressants Revenue (2021-2032) & (US$ Million) Table 134. Europe Antidepressants Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Antidepressants Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Antidepressants Sales by Type (2021-2026) & (W Units) Table 137. Europe Antidepressants Sales by Type (2027-2032) & (W Units) Table 138. Europe Antidepressants Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Antidepressants Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Antidepressants Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Antidepressants Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Antidepressants Sales by Application (2021-2026) & (W Units) Table 143. Europe Antidepressants Sales by Application (2027-2032) & (W Units) Table 144. Europe Antidepressants Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Antidepressants Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Antidepressants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Antidepressants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Antidepressants Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 150. Europe Antidepressants Sales by Country (2021-2026) & (W Units) Table 151. Europe Antidepressants Sales by Country (2027-2032) & (W Units) Table 152. Europe Antidepressants Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Antidepressants Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Antidepressants Revenue (2021-2032) & (US$ Million) Table 155. France Antidepressants Revenue (2021-2032) & (US$ Million) Table 156. U.K. Antidepressants Revenue (2021-2032) & (US$ Million) Table 157. Italy Antidepressants Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Antidepressants Revenue (2021-2032) & (US$ Million) Table 159. China Antidepressants Revenue by Type (2021-2026) & (US$ Million) Table 160. China Antidepressants Revenue by Type (2027-2032) & (US$ Million) Table 161. China Antidepressants Sales by Type (2021-2026) & (W Units) Table 162. China Antidepressants Sales by Type (2027-2032) & (W Units) Table 163. China Antidepressants Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Antidepressants Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Antidepressants Revenue by Application (2021-2026) & (US$ Million) Table 166. China Antidepressants Revenue by Application (2027-2032) & (US$ Million) Table 167. China Antidepressants Sales by Application (2021-2026) & (W Units) Table 168. China Antidepressants Sales by Application (2027-2032) & (W Units) Table 169. China Antidepressants Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Antidepressants Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Antidepressants Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Antidepressants Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Antidepressants Sales by Type (2021-2026) & (W Units) Table 174. Asia Antidepressants Sales by Type (2027-2032) & (W Units) Table 175. Asia Antidepressants Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Antidepressants Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Antidepressants Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Antidepressants Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Antidepressants Sales by Application (2021-2026) & (W Units) Table 180. Asia Antidepressants Sales by Application (2027-2032) & (W Units) Table 181. Asia Antidepressants Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Antidepressants Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Antidepressants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Antidepressants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Antidepressants Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 187. Asia Antidepressants Sales by Country (2021-2026) & (W Units) Table 188. Asia Antidepressants Sales by Country (2027-2032) & (W Units) Table 189. Asia Antidepressants Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Antidepressants Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Antidepressants Revenue (2021-2032) & (US$ Million) Table 192. South Korea Antidepressants Revenue (2021-2032) & (US$ Million) Table 193. India Antidepressants Revenue (2021-2032) & (US$ Million) Table 194. Australia Antidepressants Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Antidepressants Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Antidepressants Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Antidepressants Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Antidepressants Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Antidepressants Sales by Type (2021-2026) & (W Units) Table 200. SAMEA Antidepressants Sales by Type (2027-2032) & (W Units) Table 201. SAMEA Antidepressants Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Antidepressants Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Antidepressants Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Antidepressants Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Antidepressants Sales by Application (2021-2026) & (W Units) Table 206. SAMEA Antidepressants Sales by Application (2027-2032) & (W Units) Table 207. SAMEA Antidepressants Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Antidepressants Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Antidepressants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Antidepressants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Antidepressants Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 213. SAMEA Antidepressants Sales by Country (2021-2026) & (W Units) Table 214. SAMEA Antidepressants Sales by Country (2027-2032) & (W Units) Table 215. SAMEA Antidepressants Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Antidepressants Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Antidepressants Revenue (2021-2032) & (US$ Million) Table 218. Argentina Antidepressants Revenue (2021-2032) & (US$ Million) Table 219. Chile Antidepressants Revenue (2021-2032) & (US$ Million) Table 220. Colombia Antidepressants Revenue (2021-2032) & (US$ Million) Table 221. Peru Antidepressants Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Antidepressants Revenue (2021-2032) & (US$ Million) Table 223. Israel Antidepressants Revenue (2021-2032) & (US$ Million) Table 224. UAE Antidepressants Revenue (2021-2032) & (US$ Million) Table 225. Turkey Antidepressants Revenue (2021-2032) & (US$ Million) Table 226. Iran Antidepressants Revenue (2021-2032) & (US$ Million) Table 227. Egypt Antidepressants Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Antidepressants Distributors List Table 231. Antidepressants Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Antidepressants Image Figure 2. Global Antidepressants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidepressants Market Size Share 2021 VS 2025 VS 2032 Figure 4. Benzodiazepines Image Figure 5. Monoamine Oxidase Inhibitors Image Figure 6. Antipsychotics Image Figure 7. Tricyclic Antidepressants Image Figure 8. Novel Agents Image Figure 9. Selective Norepinephrine Reuptake Inhibitors Image Figure 10. Selective Serotonin Reuptake Inhibitors Image Figure 11. Global Antidepressants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Antidepressants Market Size Share 2021 VS 2025 VS 2032 Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Other Image Figure 16. Global Antidepressants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Antidepressants Revenue (2021-2032) & (US$ Million) Figure 18. Global Antidepressants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Antidepressants Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Antidepressants Revenue Market Share by Region (2021-2032) Figure 21. Global Antidepressants Sales (2021-2032) & (W Units) Figure 22. Global Antidepressants Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Antidepressants Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Antidepressants Sales YoY (2021-2032) & (W Units) Figure 25. Europe Antidepressants Sales YoY (2021-2032) & (W Units) Figure 26. China Antidepressants Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Antidepressants Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Antidepressants Sales YoY (2021-2032) & (W Units) Figure 29. Global Antidepressants Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Antidepressants Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Antidepressants Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Antidepressants Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Antidepressants Revenue Market Share by Type (2021-2032) Figure 35. Global Antidepressants Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Antidepressants Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Antidepressants Sales Market Share by Type (2021-2032) Figure 38. Global Antidepressants Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Antidepressants Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Antidepressants Revenue Market Share by Application (2021-2032) Figure 41. Global Antidepressants Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Antidepressants Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Antidepressants Sales Market Share by Application (2021-2032) Figure 44. North America Antidepressants Revenue Share by Type (2021-2032) Figure 45. North America Antidepressants Sales Share by Type (2021-2032) Figure 46. North America Antidepressants Revenue Share by Application (2021-2032) Figure 47. North America Antidepressants Sales Share by Application (2021-2032) Figure 48. North America Antidepressants Revenue Share by Country (2021-2032) Figure 49. North America Antidepressants Sales Share by Country (2021-2032) Figure 50. Europe Antidepressants Revenue Share by Type (2021-2032) Figure 51. Europe Antidepressants Sales Share by Type (2021-2032) Figure 52. Europe Antidepressants Revenue Share by Application (2021-2032) Figure 53. Europe Antidepressants Sales Share by Application (2021-2032) Figure 54. Europe Antidepressants Revenue Share by Country (2021-2032) Figure 55. Europe Antidepressants Sales Share by Country (2021-2032) Figure 56. China Antidepressants Revenue Share by Type (2021-2032) Figure 57. China Antidepressants Sales Share by Type (2021-2032) Figure 58. China Antidepressants Revenue Share by Application (2021-2032) Figure 59. China Antidepressants Sales Share by Application (2021-2032) Figure 60. Asia Antidepressants Revenue Share by Type (2021-2032) Figure 61. Asia Antidepressants Sales Share by Type (2021-2032) Figure 62. Asia Antidepressants Revenue Share by Application (2021-2032) Figure 63. Asia Antidepressants Sales Share by Application (2021-2032) Figure 64. Asia Antidepressants Revenue Share by Country (2021-2032) Figure 65. Asia Antidepressants Sales Share by Country (2021-2032) Figure 66. SAMEA Antidepressants Revenue Share by Type (2021-2032) Figure 67. SAMEA Antidepressants Sales Share by Type (2021-2032) Figure 68. SAMEA Antidepressants Revenue Share by Application (2021-2032) Figure 69. SAMEA Antidepressants Sales Share by Application (2021-2032) Figure 70. SAMEA Antidepressants Revenue Share by Country (2021-2032) Figure 71. SAMEA Antidepressants Sales Share by Country (2021-2032) Figure 72. Antidepressants Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Antidepressants Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Benzodiazepines
  • Monoamine Oxidase Inhibitors
  • Antipsychotics
  • Tricyclic Antidepressants
  • Novel Agents
  • Selective Norepinephrine Reuptake Inhibitors
  • Selective Serotonin Reuptake Inhibitors
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Bristol-Myers Squibb Company
  • H Lundbeck
  • Sun Pharmaceuticals
  • Astrazeneca
  • GlaxoSmithKline
  • Pfizer Inc.
  • Eli Lilly and Company
  • Merck
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antidepressants Market by Type
  3. 1.2.1 Global Antidepressants Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Benzodiazepines
  5. 1.2.3 Monoamine Oxidase Inhibitors
  6. 1.2.4 Antipsychotics
  7. 1.2.5 Tricyclic Antidepressants
  8. 1.2.6 Novel Agents
  9. 1.2.7 Selective Norepinephrine Reuptake Inhibitors
  10. 1.2.8 Selective Serotonin Reuptake Inhibitors
  11. 1.3 Antidepressants Market by Application
  12. 1.3.1 Global Antidepressants Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Hospitals
  14. 1.3.3 Clinics
  15. 1.3.4 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Antidepressants Market Dynamics
  1. 2.1 Antidepressants Industry Trends
  2. 2.2 Antidepressants Industry Drivers
  3. 2.3 Antidepressants Industry Opportunities and Challenges
  4. 2.4 Antidepressants Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antidepressants Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antidepressants Revenue by Region
  3. 3.2.1 Global Antidepressants Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antidepressants Revenue by Region (2021-2026)
  5. 3.2.3 Global Antidepressants Revenue by Region (2027-2032)
  6. 3.2.4 Global Antidepressants Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antidepressants Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antidepressants Sales by Region
  9. 3.4.1 Global Antidepressants Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antidepressants Sales by Region (2021-2026)
  11. 3.4.3 Global Antidepressants Sales by Region (2027-2032)
  12. 3.4.4 Global Antidepressants Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antidepressants Revenue by Manufacturers
  2. 4.1.1 Global Antidepressants Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antidepressants Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antidepressants Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antidepressants Sales by Manufacturers
  6. 4.2.1 Global Antidepressants Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antidepressants Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antidepressants Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antidepressants Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antidepressants Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antidepressants Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antidepressants Manufacturers, Product Type & Application
  13. 4.7 Global Antidepressants Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antidepressants Market CR5 and HHI
  16. 4.8.2 2025 Antidepressants Tier 1, Tier 2, and Tier 3
5 Antidepressants Market by Type
  1. 5.1 Global Antidepressants Revenue by Type
  2. 5.1.1 Global Antidepressants Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antidepressants Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antidepressants Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antidepressants Sales by Type
  6. 5.2.1 Global Antidepressants Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antidepressants Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Antidepressants Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antidepressants Price by Type
6 Antidepressants Market by Application
  1. 6.1 Global Antidepressants Revenue by Application
  2. 6.1.1 Global Antidepressants Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antidepressants Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antidepressants Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antidepressants Sales by Application
  6. 6.2.1 Global Antidepressants Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antidepressants Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Antidepressants Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antidepressants Price by Application
7 Company Profiles
  1. 7.1 Bristol-Myers Squibb Company
  2. 7.1.1 Bristol-Myers Squibb Company Company Information
  3. 7.1.2 Bristol-Myers Squibb Company Business Overview
  4. 7.1.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bristol-Myers Squibb Company Antidepressants Product Portfolio
  6. 7.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 7.2 H Lundbeck
  8. 7.2.1 H Lundbeck Company Information
  9. 7.2.2 H Lundbeck Business Overview
  10. 7.2.3 H Lundbeck Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 H Lundbeck Antidepressants Product Portfolio
  12. 7.2.5 H Lundbeck Recent Developments
  13. 7.3 Sun Pharmaceuticals
  14. 7.3.1 Sun Pharmaceuticals Company Information
  15. 7.3.2 Sun Pharmaceuticals Business Overview
  16. 7.3.3 Sun Pharmaceuticals Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceuticals Antidepressants Product Portfolio
  18. 7.3.5 Sun Pharmaceuticals Recent Developments
  19. 7.4 Astrazeneca
  20. 7.4.1 Astrazeneca Company Information
  21. 7.4.2 Astrazeneca Business Overview
  22. 7.4.3 Astrazeneca Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Astrazeneca Antidepressants Product Portfolio
  24. 7.4.5 Astrazeneca Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Antidepressants Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 Pfizer Inc.
  32. 7.6.1 Pfizer Inc. Company Information
  33. 7.6.2 Pfizer Inc. Business Overview
  34. 7.6.3 Pfizer Inc. Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Inc. Antidepressants Product Portfolio
  36. 7.6.5 Pfizer Inc. Recent Developments
  37. 7.7 Eli Lilly and Company
  38. 7.7.1 Eli Lilly and Company Company Information
  39. 7.7.2 Eli Lilly and Company Business Overview
  40. 7.7.3 Eli Lilly and Company Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly and Company Antidepressants Product Portfolio
  42. 7.7.5 Eli Lilly and Company Recent Developments
  43. 7.8 Merck
  44. 7.8.1 Merck Company Information
  45. 7.8.2 Merck Business Overview
  46. 7.8.3 Merck Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merck Antidepressants Product Portfolio
  48. 7.8.5 Merck Recent Developments
  49. 7.9 Johnson & Johnson
  50. 7.9.1 Johnson & Johnson Company Information
  51. 7.9.2 Johnson & Johnson Business Overview
  52. 7.9.3 Johnson & Johnson Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Johnson & Johnson Antidepressants Product Portfolio
  54. 7.9.5 Johnson & Johnson Recent Developments
  55. 7.10 Sanofi
  56. 7.10.1 Sanofi Company Information
  57. 7.10.2 Sanofi Business Overview
  58. 7.10.3 Sanofi Antidepressants Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Antidepressants Product Portfolio
  60. 7.10.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Antidepressants Market Size by Type
  2. 8.1.1 North America Antidepressants Revenue by Type (2021-2032)
  3. 8.1.2 North America Antidepressants Sales by Type (2021-2032)
  4. 8.1.3 North America Antidepressants Price by Type (2021-2032)
  5. 8.2 North America Antidepressants Market Size by Application
  6. 8.2.1 North America Antidepressants Revenue by Application (2021-2032)
  7. 8.2.2 North America Antidepressants Sales by Application (2021-2032)
  8. 8.2.3 North America Antidepressants Price by Application (2021-2032)
  9. 8.3 North America Antidepressants Market Size by Country
  10. 8.3.1 North America Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antidepressants Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antidepressants Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Antidepressants Market Size by Type
  2. 9.1.1 Europe Antidepressants Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antidepressants Sales by Type (2021-2032)
  4. 9.1.3 Europe Antidepressants Price by Type (2021-2032)
  5. 9.2 Europe Antidepressants Market Size by Application
  6. 9.2.1 Europe Antidepressants Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antidepressants Sales by Application (2021-2032)
  8. 9.2.3 Europe Antidepressants Price by Application (2021-2032)
  9. 9.3 Europe Antidepressants Market Size by Country
  10. 9.3.1 Europe Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antidepressants Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antidepressants Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Antidepressants Market Size by Type
  2. 10.1.1 China Antidepressants Revenue by Type (2021-2032)
  3. 10.1.2 China Antidepressants Sales by Type (2021-2032)
  4. 10.1.3 China Antidepressants Price by Type (2021-2032)
  5. 10.2 China Antidepressants Market Size by Application
  6. 10.2.1 China Antidepressants Revenue by Application (2021-2032)
  7. 10.2.2 China Antidepressants Sales by Application (2021-2032)
  8. 10.2.3 China Antidepressants Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antidepressants Market Size by Type
  2. 11.1.1 Asia Antidepressants Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antidepressants Sales by Type (2021-2032)
  4. 11.1.3 Asia Antidepressants Price by Type (2021-2032)
  5. 11.2 Asia Antidepressants Market Size by Application
  6. 11.2.1 Asia Antidepressants Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antidepressants Sales by Application (2021-2032)
  8. 11.2.3 Asia Antidepressants Price by Application (2021-2032)
  9. 11.3 Asia Antidepressants Market Size by Country
  10. 11.3.1 Asia Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antidepressants Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antidepressants Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antidepressants Market Size by Type
  2. 12.1.1 SAMEA Antidepressants Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antidepressants Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antidepressants Price by Type (2021-2032)
  5. 12.2 SAMEA Antidepressants Market Size by Application
  6. 12.2.1 SAMEA Antidepressants Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antidepressants Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antidepressants Price by Application (2021-2032)
  9. 12.3 SAMEA Antidepressants Market Size by Country
  10. 12.3.1 SAMEA Antidepressants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antidepressants Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antidepressants Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antidepressants Value Chain Analysis
  2. 13.1.1 Antidepressants Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antidepressants Production Mode & Process
  6. 13.2 Antidepressants Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antidepressants Distributors
  9. 13.2.3 Antidepressants Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst